- Home
- TGB vs LENZ Comparison
TGB vs LENZ Comparison
Compare TGB & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGB
- LENZ
- Stock Information
- Founded
- TGB 1966
- LENZ 2019
- Country
- TGB Canada
- LENZ United States
- Employees
- TGB N/A
- LENZ N/A
- Industry
- TGB Precious Metals
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- TGB Basic Materials
- LENZ Health Care
- Exchange
- TGB Nasdaq
- LENZ Nasdaq
- Market Cap
- TGB 720.2M
- LENZ 742.3M
- IPO Year
- TGB N/A
- LENZ 2021
- Fundamental
- Price
- TGB $1.98
- LENZ $25.87
- Analyst Decision
- TGB
- LENZ Strong Buy
- Analyst Count
- TGB 0
- LENZ 5
- Target Price
- TGB N/A
- LENZ $41.80
- AVG Volume (30 Days)
- TGB 15.6M
- LENZ 257.6K
- Earning Date
- TGB 05-01-2025
- LENZ 05-07-2025
- Dividend Yield
- TGB N/A
- LENZ N/A
- EPS Growth
- TGB N/A
- LENZ N/A
- EPS
- TGB N/A
- LENZ N/A
- Revenue
- TGB $417,640,101.00
- LENZ N/A
- Revenue This Year
- TGB $25.02
- LENZ N/A
- Revenue Next Year
- TGB $32.20
- LENZ $544.90
- P/E Ratio
- TGB N/A
- LENZ N/A
- Revenue Growth
- TGB 7.89
- LENZ N/A
- 52 Week Low
- TGB $1.67
- LENZ $14.42
- 52 Week High
- TGB $3.15
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- TGB 43.18
- LENZ 50.48
- Support Level
- TGB $2.18
- LENZ $25.49
- Resistance Level
- TGB $2.04
- LENZ $30.48
- Average True Range (ATR)
- TGB 0.11
- LENZ 2.23
- MACD
- TGB -0.03
- LENZ -0.09
- Stochastic Oscillator
- TGB 17.00
- LENZ 42.09
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.